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Summary
 
Antibody class switching is mediated by somatic recombination between switch regions of the
immunoglobulin heavy chain gene locus. Targeting of recombination to particular switch re-
gions is strictly regulated by cytokines through the induction of switch transcripts starting 5
 
9
 
 of
the repetitive switch regions. However, switch transcription as such is not sufficient to target
switch recombination. This has been shown in mutant mice, in which the I-exon and its pro-
moter upstream of the switch region were replaced with heterologous promoters. Here we
show that, in the murine germline targeted replacement of the endogenous 
 
g
 
1 promoter,
I-exon, and I-exon splice donor site by heterologous promoter and splice donor sites directs
switch recombination in activated B lymphocytes constitutively to the 
 
g
 
1 switch region. In
contrast, switch recombination to IgG1 is inhibited in mutant mice, in which the replacement
does not include the heterologous splice donor site. Our data unequivocally demonstrate that
targeting of switch recombination to IgG1 in vivo requires processing of the I
 
g
 
1 switch tran-
scripts. Either the processing machinery or the processed transcripts are involved in class switch
recombination. 
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B lymphocytes
 
B
 
cells can exchange, by immunoglobulin class switch
recombination, the isotype of the antibody they ex-
press during an immune response. Upon activation, gene
segments of a particular constant region (C
 
H
 
) are fused to
the variable region exons of the immunoglobulin heavy-
chain (IgH) gene. This DNA recombination occurs between
switch (s) regions located upstream of each constant region
gene (for review see references 1–3).
Switch recombination is directed to particular Ig classes
by cytokines (for review see reference 4) which induce
transcripts of individual unrearranged switch regions, the
switch transcripts, before recombination (5–8). A common
switch recombinase machinery may then recognize the
committed heavy-chain gene segments. Targeting of class
switch recombination becomes independent of cytokines if
the promoter of a particular unrearranged IgH gene seg-
ment is replaced by a constitutively active promoter (7, 8).
Switch transcription initiates from the I
 
H
 
-exon, located
upstream of the switch regions, and proceeds through the
switch region and the C
 
H
 
 exons. The switch region and the
C
 
H
 
 introns are spliced out of the switch transcript pre-
mRNA.
Little is known about the mechanism by which these
switch transcripts control class switch recombination. Nei-
ther the process of switch transcription alone nor the pro-
duction of a stable transcript is sufficient to direct switch re-
combination (7–10). Switch transcripts seem not to encode
for polypeptides involved in recombination.
It has been suggested that in addition to transcription, the
processing of switch transcripts might be necessary for class
switch recombination (7, 8). In mice that lack a 114-bp frag-
ment spanning the 3
 
9
 
 part of the I
 
g
 
1-exon and the 5
 
9
 
 part of
the s
 
g
 
1 region, including the splice donor site, class switch to
IgG1 was abolished, whereas the switch transcription, driven
by the human metallothionein (hMT) promoter, was not af-
fected. This result led to speculations on the relevance of the
splice donor site. However, an alternative explanation for
this finding could be the presence of a recombination control
element within the 114-bp fragment.
To clarify the relevance of the endogenous I
 
g
 
1-exon
splice donor site for switch recombination, we describe
here the targeted replacement of the entire endogenous
I
 
g
 
1-exon by an artificial I-exon and an adenoviral (Ad)
splice donor site. We show unambiguously that processing
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of switch transcripts, or the processed switch transcripts
themselves, are required for switch recombination.
 
Materials and Methods
 
Mice.
 
All mice used in this study were bred and kept in the
animal facility of the Institute of Genetics (University of Cologne,
Germany). CD1 female mice for preparation of morulae were
obtained from Charles River (Sulzfeld, Germany). All animal ex-
periments were performed in accordance with institutional and
state guidelines.
 
Construction of the Ad-hMT Gene-targeting Vector.
 
We amplified
the Ad splice donor site as an XhoI fragment (sequence data are
available from EMBL/GenBank/DDBJ under accession number
X02996, positions 6062 to 6241) from the plasmid pH3E-5 (a gift
from Dr. K. Hilger-Eversheim, Institute of Genetics), containing
the Ad type V–HindIII E insert cloned into the HindIII site of
pBR322. The splice donor fragment contained 28 nucleotides of
the first exon of the tripartide leader from the Ad-major–late
region (11), plus 151 nucleotides of the first intervening sequence
(12). The Ad-hMT vector has been constructed by cloning the
XhoI fragment of the Ad splice donor site into the SalI site of the
hMT targeting vector directly downstream of the neomycin resis-
tance gene (neo)–hMT promoter cassette, which includes a bac-
terial sequence replacing the I
 
g
 
1-exon. The hMT vector has been
described in detail (7). The Ad-hMT construct consisted of an 8-kb
homologous sequence to the 5
 
9
 
s
 
g
 
1 region, the replacement cassette
containing neo in reverse orientation, the hMT promoter, a bacte-
rial sequence, and the Ad splice donor site, and 0.8-kb homology
to the s
 
g
 
1 region. A thymidine kinase gene (TK) for negative
selection was introduced at the 5
 
9
 
 end of the construct.
 
Generation and Screening of Homologous Recombinant Embryonic
Stem (ES) Cell Clones.
 
The NotI linearized Ad-hMT vector was
transfected into 129/Ola derived E14-1 ES cells (13). ES cells
were cultured on primary embryonic fibroblasts and manipulated
as described in Torres and Kühn (14). Homologous recombinant
ES clones were identified by Southern blot analysis. Genomic
DNA was digested with EcoRI and hybridized with the external
9-kb SspI-EcoRI fragment of the 
 
g
 
1 switch region (15). Homol-
ogous recombinant clones were confirmed by digestion with
KpnI hybridizing with a 1,550-bp XhoI-EcoRV neomycin probe
from pFRT2neo (9).
 
Generation of Targeted Ad-hMT Mice.
 
A correctly targeted ES
cell clone was aggregated with CD1 morulae prepared from 6-wk-
old superovulated mice and implanted into foster mothers as
described previously (14). Male chimeric mice were crossed to fe-
male C57BL/6 mice to obtain heterozygous mutant mice. Off-
spring were analyzed for transmission of targeted and wild-type
IgH alleles by PCR using as the 5
 
9
 
 primer 5
 
9
 
-TAGTCCCTGC-
CTTTGCTCTG-3
 
9
 
 (primer 1) and, for the Ad-hMT allele, the
3
 
9
 
 primer 5
 
9
 
-ATCGCCTTCTTGACGAGTTC-3
 
9
 
 (primer 2),
and, for the wild-type allele, the 3
 
9
 
 primer 5
 
9
 
-GCCTCGTCAGA-
AAGATTGGT-3
 
9
 
 (primer 3). Homozygous mice were generated
by intercross.
 
Analysis of IgG1 Serum Titers and Cytometric Analysis of LPS-
stimulated Splenic B Cells.
 
Serum concentrations of IgG1
 
a
 
 and
total IgG1 of unimmunized mice were determined by allotype-
specific ELISA as described (13). The frequency of IgG1 class
switch was assayed by flow cytometric analysis of LPS- (Sigma
Chemical Co., Steinheim, Germany) activated splenic B cells in
vitro. Resting B cells were obtained by depletion of CD43
 
1
 
 cells
from spleen cells prepared from 8–12-wk-old mice using anti-
CD43 microbeads and high-gradient magnetic cell separation
(MACS; Miltenyi Biotec, Bergisch Gladbach, Germany). The ef-
ficiency of depletion was controlled by flow cytometric analysis
with anti-CD43 antibodies (Miltenyi Biotec). B cells were cul-
tured in RPMI, 10% FCS, 50 
 
m
 
M 
 
b
 
-mercaptoethanol, 2 mM
glutamin, and 10 U/ml penicillin–streptomycin in a concentra-
tion of 10
 
6
 
 cells/ml and stimulated on day 0 either with LPS
alone (40 
 
m
 
g/ml) or with LPS and recombinant murine IL-4 (5
ng/ml; Genzyme Corp., Cambridge, MA). Cells were harvested
on day 5, fixed in formaldehyde (2%; Merck, Darmstadt, Ger-
many), permeabilized by saponin (0.5%, Sigma Chemical Co.),
(16), and stained for cytoplasmic IgG1 with digoxigenized mono-
clonal rat anti–mouse IgG1 (0.5 
 
m
 
g/ml; gift from Miltenyi
Biotec) and antidigoxigenin (Boehringer Mannheim, Mannheim,
Germany) conjugated to Cy5 (Amersham, Braunschweig, Ger-
many). Cytometric analysis was performed using a FACScan
 
Ò
 
(Becton Dickinson, Mountain View, CA).
 
Results
 
Generation of Ad-hMT Targeted Mice.
 
For the genetic mod-
ification of the IgG1 locus, we constructed an Ad-hMT
targeting vector (Fig. 1 
 
A
 
). It contained a heterologous
Figure 1. Targeting of the
murine  g1 wild-type locus using
a modified hMT vector with an
inserted Ad splice donor site
(Ad-59ss). (A) Genomic organi-
zation of the murine IgG1 wild-
type locus, the targeting vector,
and the targeted Ad-hMT allele.
The sg1 probe used for Southern
screening of homologous recom-
binant ES cell clones is repre-
sented as a black bar. Filled trian-
gles indicate the primers used for
screening of chimeric offspring.
H, HindIII; E, EcoRI; Sc, ScaI;
Amp, ampicillin resistance gene; TK, herpes simplex virus thymidine kinase gene; neo, neomycin resistance gene. (B) Detail of the g1 wild-type and Ad-
hMT targeted alleles. The genomic structure is compared with the hMT and s-hMT targeted loci (7). Sequences introduced by targeting vectors are
shown in white: neo gene (neo), hMT promoter (hMT), artificial IhMT exon (IhMT); or in black: Ad splice donor site (Ad). The 114-bp fragment of wild-
type sequence is represented as a hatched box. The phenotype of the mice is indicated with respect to transcription (transcription), splicing of the transcripts
(processed transcripts), and class switch to IgG1 (class switch). 
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splice donor site inserted into the SalI site directly 3
 
9
 
 of the
neo–hMT promoter cassette of the targeting vector, which
we originally used to generate the hMT mutant mice as
described previously (7). We chose an 179-bp fragment
from Ad type V, which contains all 
 
cis
 
 elements needed for
efficient splicing, and a 9-bp splice donor site (12). No cod-
ing sequence is present in this fragment. Both the sequence
of the Ad splice donor site (GGG GTAGT) as well as the
sequence of the endogenous 
 
g
 
1 splice donor site (GCG
GTAAGT) are 78% homologous to the consensus sequence
(17). The resulting Ad-hMT construct (Fig. 1 
 
A
 
) was tar-
geted into wild-type E14-1 ES cells derived from 129/Ola
mice (IgH
 
a
 
). Homologous integration was confirmed by
Southern hybridization (Fig. 2 
 
A
 
, and data not shown). In
the mutant Ad-hMT IgH locus the endogenous 1.7-kb
5
 
9
 
s
 
g
 
1 region containing the 
 
g
 
1 promoter and the I
 
g
 
1-exon
is replaced by an inversely oriented neo, the hMT pro-
moter, a bacterial sequence replacing the I-exon and the Ad
splice donor site. The correct insertion of the Ad splice
donor site in the targeted ES cell clone was verified by se-
quencing. Thus, Ad-hMT mice and hMT mice differ only
in the presence of the Ad splice donor site (Fig. 1 
 
B
 
).
We generated nine chimeric mice by aggregation of one
ES cell clone with morulae prepared from female mice of
the CD1 outbred strain. Heterozygous targeted mice were
obtained by crossing the chimeras with C57BL/6 (IgH
 
b
 
).
Heterozygous and homozygous mutant mice were identi-
fied by PCR of genomic DNA from tail biopsies using
primers 1, 2, and 3 (Fig. 2 
 
B
 
). The effect of the inserted
splice donor site on IgG1 class switching was analyzed in
mice heterozygous and homozygous for the mutation.
 
Mutant Ad-hMT Mice Produce Normal Titers of IgG1 In Vivo.
 
To analyze IgG1 class switching in vivo we measured the
IgG1 titer in IgH
 
Ad-hMT/b
 
 mice by an allotype-specific
ELISA. Since the C57BL/6 IgH allotype produces IgG1 of
the b haplotype, analysis of the IgG1
 
a
 
 titer directly deter-
mines the IgG1 level produced from the 129/Ola derived
targeted Ad-hMT alleles (IgH
 
a
 
). In IgH
 
Ad-hMT/b
 
 mice, se-
rum IgG1
 
a
 
 concentrations were 
 
z
 
1,000-fold above the ti-
ters of IgH
 
hMT/b
 
 mice, which show a constitutive transcrip-
tion of the IgG1
 
a
 
 locus but lack the 114-bp endogenous
fragment (Fig. 3). Titers comparable to IgH
 
Ad-hMT/b
 
 mice
(mean, 365 
 
m
 
g/ml) were detected in sera of IgH
 
s-hMT/b
 
mice, which have retained the 114 bp of endogenous se-
quence (mean, 340 
 
m
 
g/ml) and in BALB/c mice (IgH
 
a/a
 
,
mean, 453 
 
m
 
g/ml). IgH
 
hMT/b
 
 mice produce very low levels
of serum IgG1
 
a
 
 (mean 0.4 mg/ml), whereas in C57BL/6
wild-type mice (IgHb/b) serum IgG1a was not detectable
(,0.2 mg/ml). All animals had comparable titers of total
IgG1 (IgG1a plus IgG1b).
IgG1 Switch Frequency of Activated B Cells in Ad-hMT
Mice. For the analysis of IgG1 class switching of B lym-
phocytes in vitro, we isolated resting B cells from homozy-
gous Ad-hMT mice (IgHAd-hMT/Ad-hMT) and wild-type lit-
termate controls by depletion of CD431 cells from spleen.
99% pure CD432, resting B cells were stimulated with LPS
or with LPS and IL-4. On day 5, activated B cells were
stained intracellularly for expression of IgG1 (Fig. 4). As
expected, B cells from wild-type mice switched to expres-
sion of IgG1 only in the presence of LPS and IL-4. Due to
Figure 2. (A) Analysis of homologous recombinant ES cell clones by
Southern blot using an sg1 probe. EcoRI digestion of genomic DNA
yielded fragment sizes of 13.0 and 8.0 kb of the wild-type (1) and Ad-
hMT (Ad) alleles, respectively. (B) Analysis of heterozygous and homozy-
gous targeted mice and C57BL/6 wild-type littermates. Agarose gel elec-
trophoresis of PCR products of tail DNA amplified with primers 1, 2,
and 3.
Figure 3. In vivo analysis of IgG1 production in heterozygous targeted
F1 and wild-type control mice. Immunoglobulin levels of IgG1a and of
total IgG1 (IgG1a and IgG1b) were determined in sera of 8–12-wk-old
mice by ELISA. The detection limit was 0.2 mg/ml.
Figure 4. Flow cytometric analysis of LPS-stimulated splenic B cells of
pooled homozygous targeted mice and their wild-type littermates. By de-
pletion of CD431 spleen cells using the MACS system, resting B cells
(CD432) were isolated and cultured with LPS or with LPS 1 IL-4. After
5 d cells were fixed and stained intracellularly for expression of IgG1. Due
to constitutive activity of the hMT promoter, class switch to IgG1 is in-
dependent of IL-4 in B cells from targeted mice. A representative exam-
ple of two independent experiments is shown. (Note that in all cultures
with IgG1 switched B cells, there is a basal level staining of all B cells for
IgG1, probably due to Fc-gR bound IgG1 on the surface.)2372 Class Switch Recombination and Splicing
constitutive activity of the hMT promoter in the targeted
mice, recombination to sg1 is independent of IL-4. Thus,
differences between the various targeted alleles became ev-
ident in B cells stimulated only with LPS. IgHAd-hMT/Ad-hMT
B cells, stimulated with LPS, switched to IgG1 at frequen-
cies comparable to IgHs-hMT/s-hMT B cells (8.3% vs. 10.6%),
whereas IgHhMT/hMT B cells did not switch to IgG1 at all
(,0.1%). In the presence of LPS plus IL-4, the frequency of
switched cells from IgHAd-hMT/Ad-hMT mice and IgHs-hMT/s-hMT
mice was enhanced by a factor of 1.4 and 1.6, respectively,
as compared to the cultures with LPS alone. This effect is
probably due to the stronger proliferative induction of
stimulated B cells by IL-4.
We conclude that processing of the Ig1 switch transcripts
is required for class switching to IgG1 in vivo and in vitro.
Discussion
Recent studies have suggested that in addition to tran-
scription, processing of switch transcripts may be required
to induce recombination of the corresponding switch re-
gion (7, 8). We have shown previously that a 114-bp frag-
ment of Ig1 wild-type sequence is necessary to target
switch recombination to IgG1 (Fig. 1 B; 7). Whether the
114-bp fragment is required as a splice donor site, a recom-
bination control element, or a transcriptional enhancer has
not been clear so far.
In this study, we demonstrate unequivocally that it is the
splice donor element which is required to target switch re-
combination to the sg1 region in vivo. In mutant Ad-hMT
mice, which contained an Ad splice donor site replacing the
114-bp fragment, serum concentrations of IgG1 were at the
same level as in wild-type mice. In contrast, serum concentra-
tions of IgG1 were reduced about three orders of magnitude
in hMT mice (Fig. 1 B) lacking the Ig1 splice donor site.
At first glance, our results contradict experiments pub-
lished recently by Harriman et al. (8), who replaced the Ia
promoter by the phosphoglycerate kinase promoter and the
entire sequence of the Ia-exon by a human hypoxanthine
phosphoribosyltransferase (hHPRT) minigene. Despite the
deletion of the endogenous Ia splice donor site, mutant
mice produce normal titers of IgA in the serum. sa switch
recombination in these mice might be due to splicing
within the intron of the hHPRT minigene 59 of the a
switch region, as suggested by the authors. However, the
data also do not exclude splicing of primary transcripts be-
tween the splice donor site of the hHPRT minigene and
the splice acceptor of the first Ca-exon, resulting in a situ-
ation comparable to B cells from Ad-hMT mice or wild-
type B cells. In another study, deletion of the entire Ie-
exon without replacement by splice signals nearly but not
completely abolishes class switch recombination to Ige
(10). Again, the residual frequency of switch recombination
to Ige could be explained by alternative splicing between
cryptic splice sites and Ce, which may occur according to
the data shown by the authors.
Our data clearly show that processing of switch tran-
scripts is required for targeting of switch recombination in
vivo. This argues against the original idea that switch tran-
scription as such may simply improve accessibility of switch
regions for the action of a switch recombinase (5, 18, and
for review see reference 4).
A different picture arises from experiments using extra-
chromosomal or integrated switch recombination substrates
in vitro (19–23). In all systems recombination between
switch regions can be detected without active transcription.
Some switch plasmids undergo recombination at high fre-
quencies only if they are transcribed (24, 25). A require-
ment for splicing of those plasmid transcripts has not been
described so far. However, in our own experiments, we
have observed that the switch recombination frequency
could be increased more than twofold on transcribed extra-
chromosomal switch substrates, transfected into activated,
primary B cells if the plasmid transcripts are spliced (Petry,
K., G. Siebenkotten, R. Christine, and A. Radbruch, manu-
script submitted for publication). This suggests that a basic
recombination frequency of extrachromosomal switch sub-
strates may be due to recombination machines other than
the switch recombinases, but for switch recombination,
transcription and splicing of transcripts may be required.
Our study does not answer the question of how switch
transcripts are involved in the process of switch recombina-
tion. An attractive idea is that the spliced switch transcripts
or the spliced intronic switch regions would interact with
the recombination machinery. Either in trans, as a compo-
nent of the switch recombinase, or in cis, rehybridizing with
the DNA template, thus stabilizing an RNA–DNA triple
helix which then could be recognized by the recombination
machinery. This idea is supported by findings that transcrip-
tion of G-rich regions, present in switch regions or in mi-
tochondrial DNA of yeast, can generate stable RNA–DNA
hybrids in vitro (23, 26, 27). Proteins with RNA- as well as
DNA-binding domains have been shown recently to be in-
volved in the recombination of switch substrates (28).
An alternative hypothesis would be that components of
the spliceosome are required for the process of recombina-
tion. Nucleophosmin and nucleolin, two of the identified
components of the recently described switch region transfer
activity (28) have been shown to be also involved in the
processing of ribosomal RNA in the nucleolus (29, 30),
which is dependent on the presence of small nucleolar ri-
bonucleoproteins (snoRNPs) (31).
The link between splicing and recombination has been
documented recently also in other transcription-based
recombination systems such as the integration of yeast in-
tron RNA into DNA via reverse splicing and the involve-
ment of genes in double strand formation during the meio-
tic recombination and in RNA splicing in yeast (32, 33).
The common basic chemistry involved in splicing of RNA
and in recombination of DNA supports the upcoming
idea that splicing may have more potential than only to
process RNA.2373 Hein et al. Brief Definitive Report
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